• TEXT SIZE

Plaque Psoriasis Symptoms

Plaque psoriasis causes raised, red patches, often with a silvery scale, known as plaques, to appear on the skin. Plaques can appear anywhere on the body. The most common locations for the plaques are on the elbows, knees, scalp, and lower back.

Plaque psoriasis can be mild, moderate, or severe

Plaque psoriasis symptoms vary from person to person. Doctors use several factors to determine the severity of a patient's psoriasis, including how much of the body's surface area is covered by psoriasis plaques.

Doctors also consider where on the body the plaques are located or the severity of the appearance of the plaque. They may also measure the severity of plaque psoriasis by how it affects a person's ability to perform daily activities. Psoriasis can have a significant impact on a person's daily activities, even if it involves a small area of the body. ENBREL is approved to treat adults with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.


Assess Your Plaque Psoriasis Symptoms

Create a profile on ENBREL.com about your plaque psoriasis symptoms that you can print and share with your doctor.

Take a few minutes to create a symptom profile that you can print and share with your dermatologist. The profile may help you and your doctor better understand the impact your plaque psoriasis has on your body and life. It may also help you start a conversation about finding the right treatment option for you.


Please see Prescribing Information, Important Safety Information, and Medication Guide for complete details about ENBREL.

Prescription ENBREL is taken by injection.

IMPORTANT SAFETY INFORMATION
Indication

Moderate to Severe Plaque Psoriasis
ENBREL is indicated for the treatment of adult patients (18 years or older) with chronic moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.

Supportive data
Moderate to Severe Plaque Psoriasis
  • In medical studies, nearly half of patients saw 75% skin clearance in 3 months. Overall, 3 out of 4 patients saw 50% skin clearance in 3 months.
10 years since FDA approval in moderate to severe plaque psoriasis
Diagnosed with plaque psoriasis?

Sign up today for more information about moderate to severe plaque psoriasis and ENBREL.

SIGN UP TODAY